Huons Co. Ltd
Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other ch… Read more
Huons Co. Ltd (243070) - Total Liabilities
Latest total liabilities as of September 2025: ₩248.98 Billion KRW
Based on the latest financial reports, Huons Co. Ltd (243070) has total liabilities worth ₩248.98 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Huons Co. Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Huons Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Huons Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Huons Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Econocom Group SE
F:1E91
|
Germany | €1.93 Billion |
|
US Masters Residential Property Fund
PINK:UMRRF
|
USA | $238.88 Million |
|
AIC Mines Limited
PINK:IAUFF
|
USA | $103.42 Million |
|
Bahnhof AB (publ)
F:3B7
|
Germany | €635.88 Million |
|
Arrow Home Group Co. Ltd. A
SHE:001322
|
China | CN¥4.48 Billion |
|
DB INC
KO:012030
|
Korea | ₩464.00 Billion |
|
Zhejiang Weigang Technology Co. Ltd. A
SHE:001256
|
China | CN¥376.51 Million |
|
Paik Kwang Ind
KO:001340
|
Korea | ₩382.49 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Huons Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Huons Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Huons Co. Ltd (2016–2024)
The table below shows the annual total liabilities of Huons Co. Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩260.31 Billion | +25.83% |
| 2023-12-31 | ₩206.87 Billion | +8.78% |
| 2022-12-31 | ₩190.17 Billion | +11.34% |
| 2021-12-31 | ₩170.80 Billion | -3.88% |
| 2020-12-31 | ₩177.70 Billion | +67.92% |
| 2019-12-31 | ₩105.83 Billion | +20.12% |
| 2018-12-31 | ₩88.10 Billion | -5.58% |
| 2017-12-31 | ₩93.31 Billion | +9.18% |
| 2016-12-31 | ₩85.47 Billion | -- |